Detection of the Production of Reactive Oxygen Species by Neutrophils in Whole Blood: Modulation by Adamantanes and Triggering by Fe3+-ions

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 54, Issue 7-8, 1999, Pages 562-568

  Schempp, Harald ^a   Albrecht Goepfert, Evelyn ^a   Elstner, Erich F ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYLTHIO 2 OXOBUTYRIC ACID; ADAMANTANE; AMANTADINE; DETECTION; EDETIC ACID; ETHYLENE; HYPOCHLOROUS ACID; MEMANTINE; NEUTROPHIL; ZYMOSAN;

ADAMANTANE; ANIMALS; FERRIC COMPOUNDS; NEUTROPHILS; REACTIVE OXYGEN SPECIES; SWINE;

EID: 0033167176     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-1999-7-816     Document Type: Article

References (45)

1. Albrecht-Goepfert E., Schempp H. and Elstner E. F. (1998), Aminoadamantane derivatives modulate the production of reactive oxygen species by pre-activated neutrophils. Biochem. Pharmacol. 56, 141-152.
2. Babior B. M. (1984), The respiratory burst of phagocytes. J. Clin. Invest. 73, 599-601.
3. Banner K. H. and Page C. P. (1996), Antiinflammatory effects of theophylline and selective phosphodiesterase inhibitors. Clin. Exp. Allergy 26, 2-9.
4. Berkow R. L., Dodson R. W., and Kraft A. S. (1987), Dissociation of human neutrophil activation events by prolonged treatment with amiloride. J. Lab. Clin. Med. 110, 97-10.
5. Berridge M. J. and Irvine R. F. (1984), Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 312, 315-321.
6. Bormann J. (1989), Memantine is a potent blocker of N-methyl-D-aspartate(NMDA) receptor channels. Europ. J. Pharmacol. 166, 591-592.
7. Brenner M., Haass A., Jacobi P. and Schimrigk K. (1989), Amantadine sulphate in treating Parkinsons disease: clinical effects, psychometric tests and serum concentrations. J. Neurol. 236, 153-156.
8. Clark R. S. B., Schiding J. K., Kaczorowski S. L., Marion D. W. and Kochanek P. M. (1994), Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. J. Neurotrauma 11, 499-506.
9. Coté, G. G. and Crain R. C. (1993), Biochemistry of phosphoinositides. Annu. Rev. Plant Physiol. Plant Mol. Biol. 44, 333-356.
10. Dawson V. L. and Dawson T. M. (1996), Free radicals and neuronal death: Cell-Death and Differentiation 3, 71-78.
11. DelRio E., Nicholls D. G. and Downes C. P. (1996), Characterization of the effects of lithium and inositol on phosphoinositide turnover in cerebellar granule cells in primary culture. J. Neurochem. 66, 517-524.
12. Deshpande S. S., Smith C. D. and Filbert M. (1995), Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Arch. Toxicol. 69, 384-390.
13. Dimpfel W. (1995), Effects of memantine on synaptic transmission in the hippocampus in vitro. Arzneim. Forsch./Drug Res. 45, 1-5.
14. Good P. F., Werner P., Hsu A., Olanow C. W. and Perl D. P. (1996). Evidence for neuronal oxidative damage in Alzheimers disease. Am. J. Pathol. 149, 21-22.
15. Götz M. E., Dirr A., Burger R., Rausch W. D. and Riederer P. (1995). High dose selegiline augments striatal ubiquinol in mouse: an indication of decreased oxidative stress or of interference with mitochondrial respiration?. A pilot studv. J. Neural. Transm.(Suppl.) 46, 149-156.
16. Hallch L. M. and Sherman W. R. (1980). The effects of lithium ion and other agents on the activity of myo- inositol-l-phosphatase from bovine brain. J. Biol. Chem. 255, 10896-10901.
17. Harris M. E., Carney J. M., Cole P. S., Hensley L. and Howard B. J. (1995). ß-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimers disease. Neuro. Report 6, 1875-1879.
18. Havlichek D. H. (1991), Antiviral drugs. In: Human Pharmacology (Wingard L. B., Brody T. M., Larner J. and Schwartz A., eds.). Mosby Year Book, Inc., 730.
19. Hippeli S., Rohnert U., Koske D. and Elstner E. F. (1997), OH-radical-type reactive oxygen species derived from superoxide and nitric oxide: A sensitive method for their determination and differentiation. Z. Naturforsch. 52c, 564-570.
20. Hippeli S. and Elstner E. F. (1990), Influence of diesel soot particles and sulfite on functions of poly- morphnuclear leukocytes. Free Rad. Res. Commun. 11 (1-3). 29-38.
21. Honegger U. E., Quack G. and Wiesmann U. N. (1994), Evidence for lysosomotropism of memantine in cultured human cells: cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and beta-adrenergic transmission. Pharma. Toxic. 73, 202-208.
22. Janoff A. J. (1985), Elastase in tissue injurv. Annu. Rev. Med. 36, 207-216.
23. Kalaria R. N. (1993), The immunopathology of Alzheimers disease and some related disorders. Brain Pathol. 3, 333-347.
24. Klebanoff S. J. (1980), Oxygen metabolism and the toxic properties of phagocvtes. Ann. Intern. Med. 93, 480-489.
25. Klee M. R. (1982), Effect of memantine on membrane properties and postsynaptic potentials in neurons of Aplysia californien. Arzneim. Forsch. 32, 1259-1267.
26. Kluter H., Vieregge P., Stolze H. and Kirchner H. (1995), Defective production of interleukin-2 in patients with idiopathic Parkinson's disease. J. Neurol. Sci. 133 (1-2), 134-139.
27. V. Kruedener S., Schempp H. and Elstner E. F. (1995). Gaschromatographic differentiation between myeloperoxidase activity and Fenton-type oxidants. Free Rad. Biol. Med. 19, 141-146.
28. Kuhn W. and Müller T. (1995), Neuroimmune mechanisms in Parkinsons disease. J. Neural. Transm. (Suppl.) 46, 229-233.
29. Lupp A., Jackisch R., Lücking C. H. and Feuerstein T. J. (1990), Effects of the antiparkinsonian drugs amantadine and memantine on striatal transmitter release in vitro. Arch. Pharmacol. 342, 86-89.
30. Majerus P. W. (1992). Inositol phosphate biochemistry. Annu. Rev. Biochem. 61, 225-250.
31. Manji H. K., Potter W. Z. and Lenox R. H. (1995), Signal transduction pathway. Arch. Gen. Psychiatry. 52, 531-543.
32. Mast H., Tatemichi T. K. and Mohr J. P. (1995), Chronic brain ischemia: the contributions of Otto Binswanger and Alois Alzheimer to the mechanism of vascular dementia. J. Neurolog. Sci. 132, 4-10.
33. Matsuo Y., Onderà, H., Shiga Y., Nakamura M. and Ninomiva M. (1994). Correlations between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Stroke 25, 1469-1475.
34. McGeer P. L. and McGeer E. G. (1995), The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218.
35. Netzer R. (1989), Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures. Europ. J. Pharm. 186, 149-156.
36. Noursharg S. (1993). Mechanisms of neutrophil and eosinophil accumulation in vivo. Am. Rev. Respir. Dis. 148, 560-564.
37. Osborne N. N. and Quack G. (1992), Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destructions of retinal neurons. Neurochem. Int. 21, 329-336.
38. Pantev M., Ritter R. and Görtelmeyer R. (1993), Clinical and behavioural evaluation in longterm care patients with mild and moderate dementia under memantine treatment. Z. Gerontol. Psychiat. 6, 103-117.
39. 2+-mobilizing inhibitors of D-myo-inositol 1,4,5-triphosphate 5-phosphatase. J. Med. Chem. 37, 907-912.
40. Schneider E., Fischer P. A., Clemens R., Balzereit F., Fünfgeld E.-W. and Haase A. J. (1984), Wirkungen oraler Memantin-Gaben auf die Parkinson-Symptomatik. Dtsch. Med. Wschr. 109, 987-990.
41. Schönberg B. S., Kokmen E. and Okazaki H. (1987), Alzheimers disease and other dementing illnesses in a defined United States population:incidence rates and clinical features. Ann. Neurol. 22, 724-729.
42. Schreiber H. and Kornhuber H. H. (1994), Das Parkinson Syndrom. Münch. Med. Wschr. 134, 302-305.
43. Skuza G., Rogoz Z., Quack G. and Danysz W. (1994), Memantine, adamantine and L-deprenyl potentiate the action of l-DOPA in monoamine-depleted rats. J. Neural. Transm.(Gen. Sect.) 98, 57-67.
44. +channels as targets for neuroprotective drugs. TIPS 16, 309-316.
45. Turner J. D., Beyreuther K. and Theuring (1996). Alzheimers Disease. Ernst Schering Research Foundation-Workshop 17. Springer PubI. Berlin-Heidelberg-New York. 213 pp.